The last 10 to 15 years has seen important advances in the management of advanced renal-cell cancer. Laura Wood, RN, MSN, OCN; Megan Price, MSN, APRN, FNP-C; and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss how real-world efficacy and safety data influence the conversations they have with their patients with advanced renal-cell carcinoma regarding treatment options.
Cleveland Clinic Taussig Cancer Center
Baylor Charles A. Sammons Cancer Center
Beth Israel Deaconess Medical Center, Harvard Medical School Teaching Hospital, Boston, MA
Last modified: September 24, 2021